Abstract
The violation of Wnt-signaling pathway and cyclic neoangiogenesis is early events in endometrial carcinogenesis. In this process an important role is played by epigenetic modifications and mutations of CDH1, CTNNB1, VEGFA genes, followed by expression violations of E-cadherin, β-catenin, VEGFA encoded by them. The aim . To study the expression levels of mRNA of CDH1, CTNNB1, VEGFA genes and the expression levels of E-cadherin, β-catenin, VEGFA in non-metastatic endometrioid endometrial carcinoma (EEC) and in EEC with metastases to regional lymph nodes. Materials and methods. Immunohistochemical study of invasive рТ 1-4 N 0 M x endometrioid endometrial carcinoma (EEC) (n=56; age – 42–83 years), invasive рТ 1-4 N 1-2 M x EEC (n=30; age – 48–79 years), samples of normal proliferative endometrium (PE) (n=30; age – 41–62 years) was performed. Molecular-genetic study of invasive рТ 1-4 N 0 M x EEC (n=10; age – 45–67 years), invasive рТ 1-4 N 1-2 M x EEC (n=10; age – 44–63 years), samples of PE (n=10; age – 46–59 years) was performed. Results. EEC is characterized by the lower mRNA expression level of CDH1 gene and by the higher mRNA expression levels of CTNNB1, VEGFA genes in comparison with the PE. E-cadherin expression level is 32.6 % lower in non-metastatic EEC and also is 58.10 % lower in metastatic EEC in comparison with the PE. β-catenin expression level is 32.56 % lower in non-metastatic EEC and also is 58.11 % lower in metastatic EEC in comparison with the PE. VEGFA expression level is 27.72 % higher in non-metastatic EEC and also is 17.87 % higher in metastatic EEC in comparison with the PE. There is lower β-catenin expression level in metastatic EEC in comparison with non-metastatic EEC. Non-metastatic and metastatic EEC is characterized by the direct medium connections between the mRNA expression levels of CTNNB1 and VEGFA genes (γ=0.44), between the mRNA expression level of CTNNB1 gene and VEGFA expression level in the tumor (γ=0.37). Conclusions . These changes contribute to tumor growth, invasion and metastasis.
Highlights
The violation of Wnt-signaling pathway and cyclic neoangiogenesis is early events in endometrial carcinogenesis
endometrial carcinoma (EEC) is characterized by the lower mRNA expression level of CDH1 gene and by the higher mRNA expression levels of cateninbeta 1 (CTNNB1), vascular endothelial growth factor A gene (VEGFA) genes in comparison with the proliferative endometrium (PE)
It was found that the levels of relative normalized mRNA expression of E-cadherin gene (CDH1) in non-metastatic and metastatic EEA reduced by 12.5 times in comparison with the normal endometrium (for non-metastatic EEC the median of expression level is 0.08 (0.05; 0.54) and for metastatic EEC the median of expression level is 0.08 (0.03; 0.29) (Table 2)
Summary
The violation of Wnt-signaling pathway and cyclic neoangiogenesis is early events in endometrial carcinogenesis. In this process an important role is played by epigenetic modifications and mutations of CDH1, CTNNB1, VEGFA genes, followed by expression violations of E-cadherin, β-catenin, VEGFA encoded by them. To study the expression levels of mRNA of CDH1, CTNNB1, VEGFA genes and the expression levels of E-cadherin, β-catenin, VEGFA in non-metastatic endometrioid endometrial carcinoma (EEC) and in EEC with metastases to regional lymph nodes
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.